A fluorine-containing ether compound represented by the following formula (1).

R.sup.1—R.sup.2—CH.sub.2—R.sup.3—CH.sub.2—R.sup.4  (1)

(R.sup.1 is an organic group having an alicyclic structure having 3 to 13 carbon atoms; R.sup.2 is represented by the following formula (2), and a in the formula (2) is an integer of 1 to 3; R.sup.3 is a perfluoropolyether chain; and R.sup.4 is a terminal group having two or three polar groups, in which individual polar groups bond to different carbon atoms and the carbon atoms to which the polar groups bond are bonded to each other through a linking group having a carbon atom to which the polar groups do not bond.)

##STR00001##

Disclosed herein are a calcium salts-supported metal catalyst, a method for preparing the same, and a method for the hydrodeoxygenation reaction of oxygenates using the same. The catalyst, in which a metal catalyst is supported on a carrier of a calcium salt, for example, calcium carbonate, has the effect of increasing the efficiency of hydrodeoxygenation reaction of oxygenates.

Disclosed herein are a calcium salts-supported metal catalyst, a method for preparing the same, and a method for the hydrodeoxygenation reaction of oxygenates using the same. The catalyst, in which a metal catalyst is supported on a carrier of a calcium salt, for example, calcium carbonate, has the effect of increasing the efficiency of hydrodeoxygenation reaction of oxygenates.

The present invention provides a crosslinking agent which can improve crosslinked fluoroelastomer high-temperature vapor resistance and a crosslinked fluoroelastomer having improved high-temperature vapor resistance. The present invention provides a compound having a structure represented by the following formula (1) (in the formula, R.sup.1 to R.sup.6 are each a hydrogen atom, a substituent, or a leaving group, and two or more of R.sup.1 to R.sup.6 are leaving groups; R.sup.a to R.sup.c are each a hydrogen atom or a substituent; and n is an integer from 2 to 5).

##STR00001##

The present invention provides a crosslinking agent which can improve crosslinked fluoroelastomer high-temperature vapor resistance and a crosslinked fluoroelastomer having improved high-temperature vapor resistance. The present invention provides a compound having a structure represented by the following formula (1) (in the formula, R.sup.1 to R.sup.6 are each a hydrogen atom, a substituent, or a leaving group, and two or more of R.sup.1 to R.sup.6 are leaving groups; R.sup.a to R.sup.c are each a hydrogen atom or a substituent; and n is an integer from 2 to 5).

##STR00001##

The present specification discloses tripartite androgen receptor eliminators (AREs), pharmaceutical compositions and medicaments comprising such AREs, methods and uses for such AREs and compositions and medicaments, and methods and uses for AREs and compositions and medicaments for treating an androgen receptor signaling-mediated condition, disease or disorder.

The present specification discloses tripartite androgen receptor eliminators (AREs), pharmaceutical compositions and medicaments comprising such AREs, methods and uses for such AREs and compositions and medicaments, and methods and uses for AREs and compositions and medicaments for treating an androgen receptor signaling-mediated condition, disease or disorder.

The invention relates to vicinal diol ether derivatives of certain polyether polymers, compositions comprising the same, and methods of making the same via reaction with substituted or unsubstituted epoxides, and methods of using the same.

A fluorine-containing ether compound according to the present invention is expressed by the following formula (1) or the following formula (2):

Q.sup.1{—(R.sup.f12).sub.m2—O—(R.sup.f11O).sub.m1-A.sup.1}.sub.n1  Formula (1)

{A.sup.1-(OR.sup.f11).sub.m1—O—(R.sup.f12).sub.m2-}.sub.n2Q.sup.2-[(R.sup.f12).sub.m2—O—(R.sup.f11O).sub.m1—(R.sup.f12).sub.m2-Q.sup.3].sub.p—(R.sup.f12).sub.m2—O—(R.sup.f11O).sub.m1—(R.sup.f12).sub.m2-Q.sup.2-{(R.sup.f12).sub.m2—O—(R.sup.f11O).sub.m1-A.sup.1}.sub.n2  Formula (2),

wherein Q.sup.1, Q.sup.2, Q.sup.3, R.sup.f11, R.sup.f12, A.sup.1, n1, n2, m1, m2, and p are as described in the specification.

The present invention is directed to novel fragrance compounds and their unexpected advantageous use in improving, enhancing or modifying a fragrance formulation through the addition of an olfactory acceptable amount of the compounds, wherein the compounds are represented by the following formula: ##STR00001## an isomer or a mixture of isomers thereof, wherein one of R and R′ represents hydrogen with the other representing a C.sub.1-C.sub.6 linear, branched, or cyclic alkyl, alkenyl, alkynyl or aromatic group; and one of the dashed lines represents a carbon-carbon single bond with the other representing a carbon-carbon double bond.